A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)
Clinical trial NCT02564614 · COMPLETED
Trial details
- NCT number
- NCT02564614
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2018-01-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.